Metraipolis › archive › dc_dc522046f138

Immune Checkpoint Therapy for Thymic Carcinoma — Europe PMC PMID:41154432

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41154432
DOI
10.3390/cancers17203377
License (as archived)
solo-consultazione
Archived
2026-11-09T04:58:17.621Z
SHA-256 of the archived text
2581d3b3d4da0ab55855718a7901a0a73d90b5b55b5ee4b7964e5122ba475b80
Stable URL of this page
https://metraipolis.com/documento/dc_dc522046f138

How to cite

Immune Checkpoint Therapy for Thymic Carcinoma — Europe PMC PMID:41154432 — Europe PMC (en), https://europepmc.org/article/MED/41154432 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dc522046f138 (Metraipolis archive dc_dc522046f138, sha256 2581d3b3d4da0ab55855718a7901a0a73d90b5b55b5ee4b7964e5122ba475b80)
BibTeX
@misc{dcdc522046f138,
  title = {Immune Checkpoint Therapy for Thymic Carcinoma — Europe PMC PMID:41154432},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41154432},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dc522046f138; sha256 2581d3b3d4da0ab55855718a7901a0a73d90b5b55b5ee4b7964e5122ba475b80},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41154432. Agents can read the archived copy with the MCP tool read_document.